Keto is Dead, Ozempic Reigns & PBM Reforms in Pennsylvania [l3uDvVU4cRV]
GLP-1 Updates: PBM Reform in Pennsylvania, Viking Therapeutics' Progress, and Emerging Weight Loss Trends
In this episode of Downsize News, hosts Christopher and Laraine Durham discuss recent updates in the GLP-1 medication landscape. Key stories include the signing of a bipartisan PBM reform bill in Pennsylvania aimed at lowering drug prices and improving transparency, the evolving prescription trends of GLP-1s for weight loss and diabetes management as observed in a study, Viking Therapeutics' advancement of their obesity drug VK2735 into Phase 3 trials, the potential discovery of new weight loss medication linked to exercise protein PGC-1 alpha, and the decline of the keto diet in favor of GLP-1 drugs like Ozempic. Join them for a live session this Thursday at 9 PM EDT post-cruise return.
🌟 DOWNSIZED GLP-1 COMPANION PRODUCT STORE:
DOWNSIZED WEBSITE:
Start your weight loss journey today! We use Mochi Health: Use Laraine’s code for $40 off: QIYGO8.
00:00 Introduction and Weekly Overview
01:08 PBM Reform in Pennsylvania
03:29 Shifts in GLP-1 Prescription Trends
05:10 Viking Therapeutics' Phase 3 Trials
08:06 New Discoveries in Weight Loss Medications
10:21 The Decline of the Keto Diet
12:24 Conclusion and Upcoming Events #does keto plus acv work #reddit keto gummies